Interaction of Sanguinarine Alkaloid, Isolated From Argemone Oil, With Hepatic Cytochrome P450 in Rats

REFERENCES

• K.M. Ansari, L.K. Chauhan, A. Dhawan, S.K. Khanna, and M. Das. (2004). Unequivocal evidence of genotoxicity of argemone oil. Int. J. Cancer 112:890–895.
   PubMed Web of Science ®Google Scholar
• K.M. Ansari, A. Dhawan, S.K. Khanna, and M. Das. (2005). In vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline comet assay in mice. Food Chem. Toxicol. 43:147–153.
   PubMed Web of Science ®Google Scholar
• C.K. Babu, S.K. Khanna, and M. Das. (2006). Safety evaluation studies on argemone oil through dietary exposure for 90 days in rats. Food Chem. Toxicol. 44:1151–1157.
   PubMed Web of Science ®Google Scholar
• C.K. Babu, S.K. Khanna, and M. Das. (2007). Adulteration of mustard cooking oil with argemone oil: Indian food regulatory policies and antioxidant therapy both need revisitation. Antioxidant Redox Signal. 9:515–525.
   PubMed Web of Science ®Google Scholar
• P. Bartak, V. Simanek, M. Vlckova, J. Ulrichova, and R. Vespalec. (2003). Interaction of sanguinarine and chelerythrine with molecules containing mercapto group. J. Phys. Org. Chem. 16:803–810.
   Web of Science ®Google Scholar
• J.D. Bethizy, and J.R. Hayes. Metabolism, a determinant of toxicityPrinciples and methods of toxicology 3rdA.W. Hayes. Raven Press, New York, (1994)59–100.
   Google Scholar
• M.D. Burke, S. Thompson, R.J. Weaver, C.R. Wolf, and R.T. Mayer. (1994). Cytochrome P450 specificities of alkoxyresorufin-o-dealkylation in human and rat liver microsomes. Biochem. Pharmacol. 48:923–926.
   PubMed Web of Science ®Google Scholar
• M. Chiba, L. Jin, W. Neway, J.P. Vacca, J.R. Tata, K. Chapman, and J.H. Lin. (2001). P450 interaction with HIV protease inhibitors: Relationship between metabolic stability, inhibitory potency and P450 binding spectra. Drug. Metab. Disp. 29:1–3.
   PubMed Web of Science ®Google Scholar
• H.G. Cohen, M. Seifen, K.D. Straub, C. Tiferbeck, and E.R. Stermitz. (1978). Structural specificity of the Na-K ATPase inhibition by Sanguinarine, an isoquinoline benzophenanthridine alkaloid. Biochem. Pharmacol. 27:2555–2558.
   PubMed Web of Science ®Google Scholar
• M. Das, and S.K. Khanna. (1997). Clinicoepidemiological, toxicological and safety evaluation studies on argemone oil. Crit. Rev. Toxicol. 27:273–297.
   PubMed Web of Science ®Google Scholar
• M. Das, K.M. Ansari, A. Dhawan, Y. Shukla, and S.K. Khanna. (2005a). Correlation of DNA damage in dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice. Int. J. Cancer 117:709–717.
   PubMed Web of Science ®Google Scholar
• M. Das, K. Babu, N.P. Reddy, and L.M. Srivastava. (2005b). Oxidative damage of plasma proteins and lipids in Epidemic Dropsy patients: alterations in antioxidant status. Biochem. Biophys. Acta. Gen. 1722:209–217.
   PubMed Web of Science ®Google Scholar
• M. Das, P.K. Seth, and H. Mukhtar. (1981). Characterisation of microsomal aryl hydrocarbon hydroxylase in rat brain. J. Pharmacol. Exp. Therap. 216:156–161.
   PubMed Web of Science ®Google Scholar
• M. Das, K.K. Upreti, and S.K. Khanna. (1991). Biochemical toxicology of Argemone oil: role of reactive oxygen species in iron catalysed lipid peroxidation. Bull. Environ. Cotam. Toxicol. 46:422–430.
   PubMed Web of Science ®Google Scholar
• D.S. Davies, P.L. Gigen, and J.R. Gillette. (1969). Species and sex differences in electron transport systems in liver microsomes and their relationship to ethylmorphine demethylation. Life Sci. 8:85–91.
   PubMed Web of Science ®Google Scholar
• J. Dostal, and M. Potacek. (1990). Quaternary bezo(c) phenathridine alkaloids. Collec. Czec. Chem. Commn. 55:2840–2873.
   Google Scholar
• F.P. Guengerich. Human cytochrome P450 enzymesCytochrome P450: Structure, Mechanism and BiochemistryP.R. Ortiz de Motellano. Plenum Press, New York, (1995)473–535.
   Google Scholar
• E.G. Hrycay, and S.M. Bandiera. (2003). Spectral interactions of tetrachlorobiphenyls with hepatic microsomal Cytochrome P450 enzymes. Chem. Biol. Interac. 146:285–296.
   PubMed Web of Science ®Google Scholar
• R.A. Jordan. Cocaine induced hepatotoxicity. University of Utah, Thesis, (1979).
   Google Scholar
• I.I. Karuzina, and A.I. Archakov. (1994). Hydrogen peroxide mediated inactivation of microsomal Cytochrome P450 during monoxygenase reactions. Free. Radic. Biol. Med. 17:557–567.
   PubMed Web of Science ®Google Scholar
• O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall. (1951). Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265–275.
   PubMed Web of Science ®Google Scholar
• D.W. Nebert, and D.W. Russel. (2002). Clinical importance of Cytochromes P450. Lancet 360:1155–1162.
   PubMed Web of Science ®Google Scholar
• P.V. Nerurkar, S.S. Prank, P.E. Thomas, R.W. Nims, and R.A. Lubet. (1993). Methoxyresorufin and Benzoyloxyresorufin: substrates preferentially metabolised by Cytochromes 1A2 and 2B respectively, in the rat and mouse. Biochem. Pharmacol. 46:933–943.
   PubMed Web of Science ®Google Scholar
• T. Omura, and R. Sato. (1964). Carbon monoxide binding pigment of rat liver microsomes. I. Evidence for its heme protein nature. J. Biol. Chem. 239:2370–2378.
   PubMed Web of Science ®Google Scholar
• P.R. Ortiz de Montellano, and M.A. Corriea. (1983). Suicidal destruction of Cytochrome P450 during oxidative drug metabolism. Annu. Rev. Pharmacol. Toxicol. 23:481–503.
   PubMed Web of Science ®Google Scholar
• A. Peeples, and R.R. Dalvi. (1982). Toxic alkaloids and their interaction with microsomal cytochrome P-450. J. Appl. Toxicol. 2:300–302.
   PubMed Web of Science ®Google Scholar
• S.N. Sarkar. (1948). Isolation from argemone oil of dihydrosanguinarine and sanguinarine. Toxicity of sanguinarine. J. Appl. Toxicol. 2:300–302.
   Google Scholar
• J.B. Schenkman, and R. Sato. (1968). The relationship between the pH induced spectral change in ferri proto heme and the substrate induced spectral change of the hepatic mixed function oxidase. Mol. Pharmacol. 4:613–620.
   PubMed Web of Science ®Google Scholar
• J.B. Schenkman, S.G. Sligar, and D.L. Cinti. Substrate interaction with Cytochrome P450Hepatic Cytochrome P450 monoxygenase system, vol. 108, International Encyclopaedia of Pharmacology and TherapeuticsJ.B. Schenkman, and R. Kupfer. Pergamon press, Oxford, (1987)587–615.
   Google Scholar
• A. Sen, and M. Maiti. (1994). Interaction of sanguinarine's iminium and alkanolamine form with calf thymus DNA. Biochem. Pharmacol. 48:2097–2102.
   PubMed Web of Science ®Google Scholar
• D.M. Stresser, S.D. Turner, A.P. Blanchard, V.P. Miller, and C.L. Crespi. (2002). Cytochrome P450 flourometric substrates: identification of isoform selective probes for rat CYP2D2 and human CYP3A4. Drug Metab. Disp. 30:845–852.
   PubMed Web of Science ®Google Scholar
• S. Tandon, M. Das, and S.K. Khanna. (1993). Biometabolic elimination and organ retention profile of argemone alkaloid, sanguinarine in rats and guinea pigs. Drug Metab. Disp. 21:194–197.
   PubMed Web of Science ®Google Scholar
• S. Tandon, M. Das, and S.K. Khanna. (1993a). Effect of sanguinarine on the transport of essential nutrients in an everted gut sac model: Role of Na+ K+ ATPase. Natural Toxins 1:235–240.
   PubMedGoogle Scholar
• J. Ulrichova, D. Walterova, V. Preininger, J. Slavik, J. Lenfeld, M. Cushman, and V. Simanek. (1983). Inhibition of acetylcholinesterase activity by some isoquinoline alkaloids. Planta Med. 48:111–115.
   PubMed Web of Science ®Google Scholar
• K.K. Upreti, M. Das, and S.K. Khanna. (1988). Biochemical toxicology of argemone alkaloids. Efects of lipid peroxidation in different subcellular fractions of liver. Toxicol. Lett. 42:301–308.
   PubMed Web of Science ®Google Scholar
• K.K. Upreti, M. Das, and S.K. Khanna. (1991a). Biochemical toxicology of Argemone oil: effect on hepatic cytochrome P-450 and xenobiotic metabolizing enzymes. J. Appl. Tox. 11:203–209.
   PubMed Web of Science ®Google Scholar
• K.K. Upreti, M. Das, and S.K. Khanna. (1991b). Role of antioxidants and scavengers of argemone oil induced toxicity in rats. Arch. Environ. Contam. Tox. 29:531–537.
   Google Scholar
• K.K. Upreti, M. Das, A. Kumar, G.B. Singh, and S.K. Khanna. (1989). Biochemical toxicology of argemone oil IV: short-term oral feeding response in rats. Toxicology 58:285–298.
   PubMed Web of Science ®Google Scholar
• K.P. Vatsis, and M.J. Coon. (2001). Ipso-substitution by Cytochrome P450 with conversion of p-Hydroxybenzene derivatives to hydroquinone: evidence for hydro peroxide-iron as active oxygen species. Arch. Biochem. Biophys. 397:119–129.
   Web of Science ®Google Scholar
• S.K. Verma, G. Dev, A.K. Tyagi, S. Goomber, and G.V. Jain. (2001). Argemone mexicana poisoning: autopsy findings in two cases. For. Sci. Int. 115:135–141.
   Google Scholar
• J. Vrba, P. Kosina, J. Ulrichova, and M. Modriansky. (2004). Involvement of Cytochrome P450 1A in sanguinarine detoxification. Toxicol. Lett. 151:375–387.
   PubMed Web of Science ®Google Scholar
• D. Walterova, J. Ulrichova, V. Preininger, V. Simanek, J. Lenfield, and J. Lasovsky. (1981). Inhibition of liver alanine amino transferase activity by some benzophenathridine alkaloids. J. Med. Chem. 24:100–1103.
   Web of Science ®Google Scholar
• Z.Y. Wang, M. Das, D.R. Bickers, and H. Mukhtar. (1988). Interaction of epicatechins derived from green tea with rat hepatic Cytochrome P450. Drug Metab. Disp. 16:98–103.
   PubMed Web of Science ®Google Scholar
• M.K. Williams, R. Dalvi, and R.R. Dalvi. (2000). Influence of 3-methylcholantherene pre-treatment on sanguinarine toxicity in mice. Vet. Hum. Toxicol. 42:196–198.
   PubMedGoogle Scholar
• A. Zdarilova, R. Vrzal, M. Rypka, J. Ulrichova, and Z. Dvorak. (2006). Investigation of sanguinarine and chelerythrine effects on CYP1A1 expression and activity on human hepatoma cells. Food Chem. Toxicol. 44:242–249.
   PubMed Web of Science ®Google Scholar